Home › Therapeutic areas › Renal › Membranous Nephropathy
Membranous Nephropathy (4 companies)
Companies with an active program in Membranous Nephropathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CLYM | Climb Bio | HematologyImmunology+1 Rare | 2 | Phase 2 | $604M | 8 |
| NKTX | Nkarta | ImmunologyNeurology+1 Rare | 1 | Phase 1 | $124M | 8 |
| TVTX | Travere Therapeutics | MetabolicRenal Rare | 1 | Approved | $4.76B | 7 |
| VERA | Vera Therapeutics | Infectious DiseaseRenal Rare | 1 | Approved | $2.15B | 6 |
No companies match.